Symptom Management of Patients with Multiple Sclerosis in Primary Care: Focus on Overlooked Symptoms

Overview

Journal Br J Gen Pract

Specialty Public Health

Date 2021 Feb 26

PMID 33632695

Citations 2

Authors

Athanasios Papathanasiou

Laura Saunders

Gillian Sare

Affiliations

Soon will be listed here.

Citing Articles

Multiple sclerosis and self-alienation: a study based on self and others representations.

Ziaie L, Mazaheri M, Zabihzadeh A, Etemadifar M, Shokri O, Contrada R BMC Psychol. 2024; 12(1):760.

PMID: 39696622 PMC: 11656560. DOI: 10.1186/s40359-024-02264-w.

Excess costs of multiple sclerosis: a register-based study in Sweden.

Murley C, Tinghog P, Teni F, Machado A, Alexanderson K, Hillert J Eur J Health Econ. 2022; 24(8):1357-1371.

PMID: 36418785 PMC: 9685028. DOI: 10.1007/s10198-022-01547-6.

References

Koch M, Glazenborg A, Uyttenboogaart M, Mostert J, De Keyser J . Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst Rev. 2011; (2):CD007295. DOI: 10.1002/14651858.CD007295.pub2. View

Rommer P, Eichstadt K, Ellenberger D, Flachenecker P, Friede T, Haas J . Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry. Mult Scler. 2018; 25(12):1641-1652. DOI: 10.1177/1352458518799580. View

Feinstein A, Rector N, Motl R . Exercising away the blues: can it help multiple sclerosis-related depression?. Mult Scler. 2013; 19(14):1815-9. DOI: 10.1177/1352458513508837. View

DeLuca J, Chiaravalloti N, Sandroff B . Treatment and management of cognitive dysfunction in patients with multiple sclerosis. Nat Rev Neurol. 2020; 16(6):319-332. DOI: 10.1038/s41582-020-0355-1. View

Thompson A, Baranzini S, Geurts J, Hemmer B, Ciccarelli O . Multiple sclerosis. Lancet. 2018; 391(10130):1622-1636. DOI: 10.1016/S0140-6736(18)30481-1. View

Kalb R, Beier M, Benedict R, Charvet L, Costello K, Feinstein A . Recommendations for cognitive screening and management in multiple sclerosis care. Mult Scler. 2018; 24(13):1665-1680. PMC: 6238181. DOI: 10.1177/1352458518803785. View

Thompson A, Toosy A, Ciccarelli O . Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol. 2010; 9(12):1182-1199. DOI: 10.1016/S1474-4422(10)70249-0. View

Miller P, Soundy A . The pharmacological and non-pharmacological interventions for the management of fatigue related multiple sclerosis. J Neurol Sci. 2017; 381:41-54. DOI: 10.1016/j.jns.2017.08.012. View

Yadav V, Bever Jr C, Bowen J, Bowling A, Weinstock-Guttman B, Cameron M . Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2014; 82(12):1083-92. PMC: 3962995. DOI: 10.1212/WNL.0000000000000250. View

10.

Heine M, van de Port I, Rietberg M, van Wegen E, Kwakkel G . Exercise therapy for fatigue in multiple sclerosis. Cochrane Database Syst Rev. 2015; (9):CD009956. PMC: 9554249. DOI: 10.1002/14651858.CD009956.pub2. View

11.

Beckerman H, Eijssen I, van Meeteren J, Verhulsdonck M, de Groot V . Fatigue Profiles in Patients with Multiple Sclerosis are Based on Severity of Fatigue and not on Dimensions of Fatigue. Sci Rep. 2020; 10(1):4167. PMC: 7058058. DOI: 10.1038/s41598-020-61076-1. View

12.

Feinstein A, Freeman J, Lo A . Treatment of progressive multiple sclerosis: what works, what does not, and what is needed. Lancet Neurol. 2015; 14(2):194-207. DOI: 10.1016/S1474-4422(14)70231-5. View

13.

Minden S, Feinstein A, Kalb R, Miller D, Mohr D, Patten S . Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013; 82(2):174-81. PMC: 3897434. DOI: 10.1212/WNL.0000000000000013. View

14.

Brenner P, Piehl F . Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions. Acta Neurol Scand. 2016; 134 Suppl 200:47-54. DOI: 10.1111/ane.12648. View